膀胱嗜铬细胞瘤的磁共振成像:综述
膀胱嗜铬细胞瘤占全部膀胱肿瘤的0.06%、占全部嗜铬细胞瘤的1%,多为功能性并分泌儿茶酚胺导致阵发性高血压、头痛、心悸和出汗。怀疑膀胱嗜铬细胞瘤时不应行膀胱镜和活检,以避免未预先使用抗肾上腺素能阻滞剂时诱发高血压危象。MRI因软组织分辨率高且可用多参数MRI区分膀胱壁各层及与其他膀胱肿物鉴别,是检测肾上腺外膀胱嗜铬细胞瘤和确定局部区域分期的优选影像方法。
要点
- 膀胱嗜铬细胞瘤占全部膀胱肿瘤0.06%、占全部嗜铬细胞瘤1%。
- 怀疑膀胱嗜铬细胞瘤时不应行膀胱镜和活检,以免未用抗肾上腺素能阻滞剂时诱发高血压危象。
- MRI因软组织分辨率高及多参数MRI可区分膀胱壁各层并与其他膀胱肿物鉴别,为优选影像方法。
核心结论
- MRI因软组织分辨率高和可采用多参数MRI区分膀胱壁各层并与其他膀胱肿物鉴别,是检测肾上腺外膀胱嗜铬细胞瘤和确定局部区域分期的优选影像方法。
研究设计与样本
- 综述,讨论膀胱嗜铬细胞瘤中MRI的适应证、各MRI序列上的表现及使用时机。
- 诊断流程以血或尿儿茶酚胺及儿茶酚胺代谢物值作出膀胱嗜铬细胞瘤的推定诊断,再用CT和MRI定位和分期以供手术切除。
关键影像表现/征象
- 综述描述膀胱嗜铬细胞瘤在各MRI序列上的表现,并讨论MRI如何将其与其他膀胱肿瘤鉴别。
临床应用与阅片要点
- 怀疑膀胱嗜铬细胞瘤时不应行膀胱镜和活检,除非操作前已给予预防性抗肾上腺素能阻滞剂,否则可能诱发高血压危象。
- 给予抗肾上腺素能药物后行肿瘤切除,并经组织学确诊。
- 膀胱嗜铬细胞瘤的鉴别诊断常被忽视,导致未用抗肾上腺素能药物即行手术切除,增加致命性高血压危象的风险,因此MRI是术前分期膀胱嗜铬细胞瘤的重要诊断工具。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Bladder pheochromocytomas (PCCs) are rare tumors that account for 0.06% of all bladder tumors and makeup 1% of all PCCs. Most PCCs are functional, and they secrete catecholamines that lead to clinical symptoms such as paroxysmal hypertension, headaches, palpitations, and sweating. However, some are nonfunctional and asymptomatic and are hence difficult to diagnose. Cystoscopy and biopsy should not be performed when bladder PCCs are suspected. They may provoke a hypertensive crisis if preventative antiadrenergic blockers are not administered prior to the procedure. The diagnostic workup begins with obtaining blood or urine catecholamine and catecholamine metabolite values to make a presumptive diagnosis of bladder PCC. Computed tomography (C.T.) and magnetic resonance imaging (MRI) are then used to localize and stage the tumor for surgical resection. MRI, due to its superior soft tissue resolution and the ability to use multiparametric MRI (mpMRI) to differentiate between layers of the bladder wall and from other bladder masses, is the optimal imaging modality to detect extra-adrenal bladder PCCs and determine locoregional staging. Once antiadrenergic medications are given, the tumor is resected, and the diagnosis is confirmed histologically. However, the differential diagnosis of bladder PCC often gets overlooked, leading to surgical resection in the absence of antiadrenergic medications, increasing the chances of a fatal hypertensive crisis. This makes MRI an essential diagnostic tool for staging bladder PCCs before surgery. This review discusses the indications for MRI in bladder PCCs and describes findings from these tumors on various MRI sequences and when to use them. We also discuss how MRI can differentiate bladder PCCs from other bladder neoplasms.
引用
- Zulia, Gopireddy, Virarkar, et al. Magnetic resonance imaging of bladder pheochromocytomas: a review. Abdom Radiol (NY). 2022. PMID: 35347385. doi:10.1007/s00261-022-03483-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。